Physician profile
Ira Savetsky
NPI 1871883421
$4,879.19
in general payments reported to CMS, 2019-2025
12 companies · $440 in 2025
The $440 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $2,227 · 2021: $309 · 2022: $657 · 2023: $182 · 2024: $614 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,177 · Entertainment: $59.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,176.91 |
| Entertainment | $59.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $2,817.04 | 2019-2025 | |
| Allergan, INC. | $529.44 | 2019-2022 | |
| Abbvie INC. | $381.68 | 2020-2025 | Natrelle Saline-Filled Breast Implants |
| Sientra, INC. | $374.05 | 2020-2022 | |
| Merz North America, INC. | $307.40 | 2020-2022 | |
| Revance Therapeutics, INC. | $188.33 | 2024 | Daxxify |
| Galderma Laboratories, L.P. | $99.91 | 2020-2023 | |
| Bard Peripheral Vascular, INC. | $71.43 | 2021 | |
| Mentor Worldwide LLC | $40.05 | 2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $35.40 | 2020-2021 | |
| Integra Lifesciences Corporation | $17.61 | 2020 | |
| Genzyme Corporation | $16.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ira Savetsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.